Affiliation:
1. Department of Medicine, Case Western Reserve University, Cleveland Metropolitan General Hospital, Ohio 44109.
Abstract
Candida lusitaniae has been an infrequently reported opportunistic pathogen. Most previously reported cases of serious infection caused by this organism have proven fatal and were associated with amphotericin resistance of the organism. We report two patients with hematologic malignancies undergoing cytotoxic chemotherapy who developed fungemia with this organism while they were granulocytopenic. The organisms isolated from each patient were fully susceptible and were treated successfully with amphotericin B. When isolated from an immunocompromised host, C. lusitaniae should be considered an opportunistic pathogen and undergo antifungal susceptibility testing. Amphotericin B should be considered the drug of choice, but a poor clinical response may be indicative of a resistant isolate.
Publisher
American Society for Microbiology
Reference21 articles.
1. Medically important yeasts. Annu;Ahearn D. G.;Rev. Microbiol.,1978
2. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida Iusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole;Ahearn D. G.;J. Clin. Microbiol.,1984
3. Candida Iusitaniae: a new opportunistic pathogen of the urinary tract;Baker J. G.;Diagn. Microbiol. Infect. Dis.,1984
4. Transient fungemia due to Candida lusitaniae;Bradsher R. W.;South. Med. J.,1985
5. Candida Iusitaniae: an emerging human pathogen;Christenson J. C.;Pediatr. Infect. Dis. J.,1987
Cited by
113 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献